ADVANCED WOUND MANAGEMENT
Breast surgery
Therapeutic mastectomy and reduction mammoplasty are both considered to be common procedures,1,2 but surgical site complications (SSCs), often associated with certain patient risk factors,3 can lead to substantial additional costs,4,5 potential delays to adjuvant treatment6,7 and a reduction in scar quality8
Back at home, not back in hospital
Implementing a formal protocol for prophylactic use of the PICO◊ Single Use Negative Pressure Wound Therapy System (sNPWT) has been shown to significantly reduce the odds of developing a SSI by 64%*11 and reduce the incidence of dehiscence,12,13 while reducing costs.9,14
- Studies have shown a 63% relative reduction in major seroma incidence,**14 and a 75% reduction in the incidence of wound dehiscence**11
- Reducing the incidence of wound breakdown and implant loss enabled an estimated cost saving of £426 per patient, compared to standard dressings**9
- Studies have shown a significant reduction of 38% in the incidence of post-surgical dehiscence***12 and a significant 50% reduction in incidence of dehiscence in bilateral procedures***15
- Scar quality following reduction mammoplasty was shown to be improved at 42 & 90 days post-surgery****12,16
Products
Medical Education
No results.
See all the other courses we have
Disclaimers
*Compared to care with standard dressings; p=0.04; meta-analysis of 2 studies (OR: 0.36). n=420.
**Compared to standard care. Seroma incidence - n= 37 v n = 23; 16.2 vs 43.5%; p=0.02. Wound dehiscence incidence - n=24.
***Compared to care with standard dressings; p<0.001. Bilateral procedures - n=32; p<0.001.
****Compared to standard care; p<0.001 at 42 and 90 days. Bilateral procedures - p<0.05; n=32.
Citations
1. Ng SK, et al. Annals of plastic surgery. 2016 Jun 1;76(6):640-4.
2. The Aesthetic Society (2020) Aesthetic Plastic Surgery National Databank 2020 Statistics.
3. Olsen MA, et al. J Am Coll Surg. 2008 Sep;207(3):326-35.
4. Olsen MA, et al. Archives of Surgery. 2008 Jan 1;143(1):53-60.
5. Tanner J, et al. Journal of Infection Prevention. 2011 Sep;12(5):204-9.
6. McIntosh J, et al. European Journal of Surgical Oncology (EJSO). 2012 Mar 1;38(3):196-202.
7. Vincent SM, et al. Advances in Breast Cancer Research. 2019 Jun 27;8(3):87-111.
8 Galiano R et al. Poster presentation CSAWC 2014
9. Irwin GW, et al. Plast Reconstr Surg Glob Open. 2020;8(e2667).
10. Nelson JA, et al. Journal of plastic surgery and hand surgery. 2014 Oct 1;48(5):334-9.
11. Holt R, et al. British Journal of Hospital Medicine. 2015;76(4).
12. Galiano RD, et al. Plastic and Reconstructive Surgery Global Open. 2018 Jan;6(1).
13. Nherera LM, et al. Journal of Wound Care. 2021 May 1;30(Sup5):S23-31.
14. Ryu JY, et al. Aesthetic Plastic Surgery. 2021 Jan 20:1-9.
15. Galiano R, et al. Paper presented at: The British Association of Aesthetic Plastic Surgeons (BAAP's) 30th Annual Scientific Meeting; 2014; London.
16. Tanaydin V, et al. Aesthetic Plast Surg. 2018;42(4):927-935.
17. Hudson DA, et al. Int Wound J. 2015;12(2):195-201.
18. Smith+Nephew 2019. Internal report. RD/18/134 V2.
19. Smith+Nephew 2017. Internal report. DS/17/253/R.
20. Smith+Nephew 2018. Internal Report. RD/18/133.
Title
Text